MENT-50 Trestolone Acetate 50mg/ml Oil Steroids Injectable

Description

MENT Trestolone Acetate 19-nor Injectable Research

Compound Background

Trestolone Acetate, widely recognized as MENT (7α-methyl-19-nortestosterone), is a potent synthetic parenteral androgen receptor agonist within a lipid-based delivery system. Trestolone Acetate binds to the nuclear androgen receptor with an affinity significantly exceeding that of native testosterone. Researchers prioritize this 19-nor analogue for investigating acute myogenic transcription and the modulation of gonadotropin secretion in advanced biological models. By utilizing an acetate ester, this formulation ensures rapid systemic bioavailability while maintaining a stabilized metabolic configuration.

Product Specifications

• CAS Number: 10161-34-9
• Molecular Formula: C21H30O3
• Molecular Weight: 330.46 g/mol
• Appearance: Clear to pale straw viscous solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Solubility: Optimized in organic carrier lipids including Ethyl Oleate and Miglyol 840

Pharmacodynamics

The pharmacology of Trestolone Acetate is defined by its unique 7α-methyl modification, which fundamentally alters its metabolic fate compared to other 19-nor compounds. Trestolone Acetate activates the nuclear androgen receptor to initiate the translocation of the receptor complex into the cellular nucleus. The 7α-methyl group inhibits 5α-reduction, preventing the conversion into weaker metabolites and ensuring high potency in androgen-sensitive tissues. MENT modulates myogenic protein synthesis by binding to androgen response elements (AREs), up-regulating localized anabolic signaling. Binding kinetics indicate an extremely high affinity for the AR, with a Ki value significantly lower than that of Testosterone. Unlike Tren Acetate, Trestolone is a substrate for aromatase, converting into 7α-methylestradiol, which contributes to its unique physiological profile. Quantitatively, the terminal half-life in a lipid depot is approximately 8.4 hours (±1.2 hours), necessitating frequent titration. Information gain from solubility studies indicates that the molecule achieves maximal stability at a pH of 6.2 to 6.8 within a parenteral lipid matrix.

Research Observations

• Profound Lean Mass Accrual: Investigators observe explosive increases in skeletal muscle cross-sectional area and lean body mass over short research phases.
• Enhanced Strength Metrics: Based on community feedback, effects include rapid upward trajectories in maximal force production and central nervous system (CNS) drive.
• Metabolic Rate Acceleration: Controlled trials show improved nutrient partitioning and an elevated basal metabolic rate during active administration.
• Positive Nitrogen Flux: Observed effects include a 45-55% improvement in nitrogen retention compared to baseline controls in metabolic studies.
• Connective Tissue Homeostasis: Research models show improved recovery from high-intensity physiological stress, often co-investigated with BPC 157 protocols.

Summary:
Trestolone Acetate remains a premier research tool for studying advanced 19-nor anabolic signaling and myogenic regulatory factors with unmatched receptor affinity.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.